Launch of €10m project to provide tailored treatment for Motor Neurone Disease 

Motor Neurone Disease research is being supported by the Irish government through a Science Foundation Ireland (SFI) investment of €5 million and an additional €5 million from industry partners.

A €10m Irish-led project has been launched to deliver more tailored treatment to those with Motor Neuron Disease (MND), using analysis of big data and artificial intelligence.

MND, also known as Amyotrophic Lateral Sclerosis (ALS), causes progressive decline in movement, cognition and behaviour, and is a terminal disease with no effective treatments. Research has shown that it is caused by variable combinations of faulty genes that likely interact with lifestyle and environment.